SEP 8, 2026 · OBSERVATIONAL STUDY
Role of Tumor Microbiota in the Response to Neoadjuvant Therapy in Patients Affected by Triple Negative Breast Cancer
ClinicalTrials.gov
This is a recruiting observational study with no posted results; it aims to characterize microbiota and immune features as potential biomarkers in triple-negative breast cancer but has not yet generated outcome data.
Reported
Planned enrollment30
Primary outcome measure 1Intratumoral microbiota characterization fr…
Primary outcome measure 2Tumor immune microenvironment characterizat…